Pharmacy Diversion Awareness Conference
August 3 & 4, 2013; Marriott Baton Rouge; Baton Rouge, Louisiana
The Drug Enforcement Administration (DEA) held a Pharmacy Diversion Awareness Conference (PDAC) on August 3rd & 4th, 2013 in Baton Rouge, LA. This was a one-day conference, repeated on the second day, for the convenience of the pharmacy community. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate pharmacists, pharmacy technicians, and pharmacy loss prevention personnel on ways to address and respond to potential diversion activity.
Over 250 pharmacists, pharmacy technicians, and loss prevention personnel attended. The conference attendees received approximately seven hours of instruction on a variety of topics. The presentations included: Drug Trends, Drugs, Drugs and More Drugs, Louisiana Rules for Controlled Substances, CMEA Requirements & Synthetic Drug Update, Pharmaceutical Diversion in Medicare Part D, Drug Theft Prevention and Combating Pharmacy Diversion.
Select presentations from the Baton Rouge PDAC, as well as a link to the Pharmacy Robbery & Burglary brochure, are below.
Drug Trends – Thomas Prevoznik, Staff Coordinator, Liaison & Policy Section, DEA Office of Diversion Control
Drugs, Drugs, and More Drugs – Malcolm Broussard, Executive Director, Louisiana Board of Pharmacy
Louisiana Rules for Controlled Substances – Malcolm Broussard, Executive Director, Louisiana Board of Pharmacy
CMEA Requirements and Synthetic Drug Update – Robert J Bell, Staff Coordinator, Synthetic Drugs and Chemicals Section, DEA Office of Diversion Control
Pharmaceutical Diversion in Medicare Part D – Les W. Hollie, Assistant Inspector General for Investigations, OIG/HHS
Drug Theft Prevention – Thomas Prevoznik, Staff Coordinator, Liaison and Policy Unit, Office of Diversion Control, DEA
Combating Pharmacy Diversion – Cathy Gallagher, Chief, Liaison & Policy Section, DEA Office of Diversion Control